Stoke Therapeutics stays a Buy as zorevunersen hits key Dravet milestones and STK-002 advances; strong cash runway to 2028.
Small cell lung cancer (SCLC) is an aggressive malignancy with limited treatment options and poor prognosis. Understanding ...
Metabolic dysfunction-associated steatotic liver disease (MASLD), which affects about 30% of the population worldwide, is ...
Morning Overview on MSN
Flu viruses force their way into cells by dissolving tiny structures in the nucleus
Influenza A virus dismantles paraspeckles, small RNA-scaffolded structures inside the cell nucleus, to suppress antiviral ...
CHARLOTTE, N.C., July 28, 2026 (GLOBE NEWSWIRE) -- via IBN -- (Nasdaq: GRML) ("Greenland Mines" or the "Company") today announced that Innovation, Science and Economic Development Canada has granted ...
Researchers have developed Fullscope-seq, a long-read spatial transcriptomics platform that maps alternative transcript isoforms within intact tissues at single-cell resolution - opening new ...
Researchers utilizes single-cell long-read sequencing to reveal thousands of previously invisible tumor-specific isoforms in ...
KRRO-121, a potential first-in-class transformational treatment for hyperammonemia, remains on track to commence first-in-human clinical trial in ...
Researchers at The Institute of Cancer Research, London, working with Merck KGaA, have developed the first potent small-molecule inhibitors of DHX8, an enzyme involved in pre-mRNA splicing. The ...
In Alzheimer’s disease and related Tauopathies, irregular post‑translational modifications, misfolding, and the build-up of ...
Cells transcribe active genes into messenger RNA molecules, using a crucial complex known as RNA polymerase II. These mRNA transcripts are then translated | Genetics ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results